{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:13:14Z","timestamp":1771920794163,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471690"],"award-info":[{"award-number":["81471690"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation for Young Scientists","award":["81701734"],"award-info":[{"award-number":["81701734"]}]},{"name":"Science and Technology Plan of Jiangsu Province-Standardization of Diagnosis and Treatment of Key Diseases Project","award":["BE2015635"],"award-info":[{"award-number":["BE2015635"]}]},{"name":"Key Project of Science and Technology Development Fund of Nanjing Medical University","award":["2017NJMUZD039"],"award-info":[{"award-number":["2017NJMUZD039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Nonalcoholic fatty liver disease (NAFLD) is a multisystem disease that affects the liver and a variety of extra-hepatic organ systems. This study aimed to investigate the relationship between hepatic steatosis and glucose metabolism in liver and extra-hepatic tissues and organs.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The whole body <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose (FDG) positron emission tomography (PET)\/computed tomography (CT) images of 191 asymptomatic tumor screening patients were retrospectively analyzed. Patients with the ratio of spleen\/liver CT densities &gt;\u20091.1 were defined to have NAFLD, and their clinical symptoms, laboratory markers, FDG uptake in a variety of tissues and organs including heart, mediastinal blood pool, liver, spleen, pancreas, and skeletal muscle, as well as abdominal adipose tissue volumes including visceral adipose tissue (VAT) volume and subcutaneous adipose tissue (SAT) volume were compared with those of the non-NAFLD patients and used to analyze the independent correlation factors of NAFLD.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Among the 191 patients, 33 (17.3%) were NAFLD, and 158 (82.7%) were non-NAFLD. There was no significant correlation between the mean standardized uptake value (SUVmean) and CT density of liver as well as the ratio of spleen\/liver CT densities. Hepatic steatosis, but not FDG intake, was more significant in NAFLD patients with abnormal liver function than those with normal liver function. Compared with the non-NAFLD patients, NAFLD patients had significantly reduced myocardial glucose metabolism, but significantly increased mediastinal blood pool, spleen SUVmean and abdominal adipose tissue volumes (including VAT and SAT volumes) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Multivariate regression analysis showed that elevated serum ALT, increased abdominal VAT volume, and decreased myocardial FDG uptake were independent correlation factors for NAFLD. Further studies showed that hepatic steatosis and myocardial FDG uptake were mildly linearly correlated (<jats:italic>r<\/jats:italic>\u2009=\u20090.366 with hepatic CT density and\u2009\u2212\u20090.236 with the ratio of spleen\/liver CT densities, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>NAFLD is a systemic disease that can lead to the change of glucose metabolism in some extra-hepatic tissues and organs, especially the myocardium.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12902-020-00556-x","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T12:03:00Z","timestamp":1590580980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by 18F-FDG PET\/CT"],"prefix":"10.1186","volume":"20","author":[{"given":"Lijun","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuetao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"556_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jhep.2008.10.010","volume":"50","author":"JG Fan","year":"2009","unstructured":"Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol. 2009;50:204\u201310.","journal-title":"J Hepatol"},{"key":"556_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328\u201357.","journal-title":"Hepatology"},{"key":"556_CR3","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313:2263\u201373.","journal-title":"JAMA"},{"key":"556_CR4","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005\u201323.","journal-title":"Hepatology"},{"key":"556_CR5","first-page":"1","volume":"17","author":"C Chen","year":"2004","unstructured":"Chen C, Lu FC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17:1\u201336.","journal-title":"Biomed Environ Sci"},{"key":"556_CR6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc17-S001","volume":"40","author":"Association AD","year":"2017","unstructured":"Association AD. Standards of medical care in diabetes-2017. Diabetes Care. 2017;40:S1\u2013S135.","journal-title":"Diabetes Care"},{"key":"556_CR7","first-page":"390","volume":"35","author":"Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults","year":"2007","unstructured":"Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35:390.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"556_CR8","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1210\/jc.2017-02584","volume":"103","author":"T Wang","year":"2018","unstructured":"Wang T, Zhao Z, Xu Y, Qi L, Xu M, Lu J, Li M, Chen Y, Dai M, Zhao W, Ning G, Wang W, Bi Y. Insulin resistance and beta-cell dysfunction in relation to cardiometabolic risk patterns. J Clin Endocrinol Metab. 2018;103:2207\u201315.","journal-title":"J Clin Endocrinol Metab"},{"key":"556_CR9","first-page":"2334","volume":"6","author":"W Sun","year":"2016","unstructured":"Sun W, Lu J, Wu S, Bi Y, Mu Y, Zhao J, Liu C, Chen L, Shi L, Li Q, Yang T, Yan L, Wan Q, Liu Y, Wang G, Luo Z, Tang X, Chen G, Huo Y, Gao Z, Su Q, Ye Z, Wang Y, Qin G, Deng H, Yu X, Shen F, Chen L, Zhao L, Wang T, Sun J, Xu M, Xu Y, Chen Y, Dai M, Zhang J, Zhang D, Lai S, Li D, Ning G, Wang W. Association of insulin resistance with breast, ovarian, endometrial and cervical cancers in non-diabetic women. Am J Cancer Res. 2016;6:2334\u201344.","journal-title":"Am J Cancer Res"},{"key":"556_CR10","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/MNM.0000000000001092","volume":"40","author":"X Shao","year":"2019","unstructured":"Shao X, Shao X, Niu R, Xing W, Wang Y. A simple prediction model using fluorodeoxyglucose-PET and high-resolution computed tomography for discrimination of invasive adenocarcinomas among solitary pulmonary ground-glass opacity nodules. Nucl Med Commun. 2019;40:1256\u201362.","journal-title":"Nucl Med Commun"},{"key":"556_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12872-018-0943-9","volume":"18","author":"L Hu","year":"2018","unstructured":"Hu L, Qiu C, Wang X, Xu M, Shao X, Wang Y. The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based 18F-FDG PET\/CT study. BMC Cardiovasc Disord. 2018;18:203.","journal-title":"BMC Cardiovasc Disord"},{"key":"556_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00259-015-3166-7","volume":"43","author":"S Ozguven","year":"2016","unstructured":"Ozguven S, Ones T, Yilmaz Y, Turoglu HT, Imeryuz N. The role of active brown adipose tissue in human metabolism. Eur J Nucl Med Mol Imaging. 2016;43:355\u201361.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"556_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.compbiomed.2016.02.013","volume":"71","author":"E Goceri","year":"2016","unstructured":"Goceri E, Shah ZK, Layman R, Jiang X, Gurcan MN. Quantification of liver fat: a comprehensive review. Comput Biol Med. 2016;71:174\u201389.","journal-title":"Comput Biol Med"},{"key":"556_CR14","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440\u201363.","journal-title":"J Am Soc Echocardiogr"},{"key":"556_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s13139-013-0230-8","volume":"47","author":"J Jeong","year":"2013","unstructured":"Jeong J, Kong E, Chun K, Cho I. The impact of energy substrates, hormone level and subject-related factors on physiologic myocardial (18) F-FDG uptake in normal humans. Nucl Med Mol Imaging. 2013;47:225\u201331.","journal-title":"Nucl Med Mol Imaging"},{"key":"556_CR16","doi-asserted-by":"publisher","first-page":"E496","DOI":"10.1152\/ajpendo.00128.2013","volume":"305","author":"MH Reichkendler","year":"2013","unstructured":"Reichkendler MH, Auerbach P, Rosenkilde M, Christensen AN, Holm S, Petersen MB, Lagerberg A, Larsson HB, Rostrup E, Mosbech TH, Sjodin A, Kjaer A, Ploug T, Hoejgaard L, Stallknecht B. Exercise training favors increased insulin-stimulated glucose uptake in skeletal muscle in contrast to adipose tissue: a randomized study using FDG PET imaging. Am J Physiol Endocrinol Metab. 2013;305:E496\u2013506.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"556_CR17","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jcmg.2012.11.021","volume":"6","author":"KJ Rosenquist","year":"2013","unstructured":"Rosenquist KJ, Pedley A, Massaro JM, Therkelsen KE, Murabito JM, Hoffmann U, Fox CS. Visceral and subcutaneous fat quality and cardiometabolic risk. JACC Cardiovasc Imaging. 2013;6:762\u201371.","journal-title":"JACC Cardiovasc Imaging"},{"key":"556_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2214\/AJR.13.12147","volume":"203","author":"G Keramida","year":"2014","unstructured":"Keramida G, Potts J, Bush J, Verma S, Dizdarevic S, Peters AM. Accumulation of (18) F-FDG in the liver in hepatic steatosis. AJR Am J Roentgenol. 2014;203:643\u20138.","journal-title":"AJR Am J Roentgenol"},{"key":"556_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ejrad.2014.01.027","volume":"83","author":"G Keramida","year":"2014","unstructured":"Keramida G, Potts J, Bush J, Dizdarevic S, Peters AM. Hepatic steatosis is associated with increased hepatic FDG uptake. Eur J Radiol. 2014;83:751\u20135.","journal-title":"Eur J Radiol"},{"key":"556_CR20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1148\/radiol.09090768","volume":"254","author":"JT Abele","year":"2010","unstructured":"Abele JT, Fung CI. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values. Radiology. 2010;254:917\u201324.","journal-title":"Radiology"},{"key":"556_CR21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jhep.2017.11.023","volume":"68","author":"YH Lee","year":"2018","unstructured":"Lee YH, Kim KJ, Yoo ME, Kim G, Yoon HJ, Jo K, Youn JC, Yun M, Park JY, Shim CY, Lee BW, Kang SM, Ha JW, Cha BS, Kang ES. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients. J Hepatol. 2018;68:764\u201372.","journal-title":"J Hepatol"},{"key":"556_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","volume":"5","author":"DG Tiniakos","year":"2010","unstructured":"Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol. 2010;5:145\u201371.","journal-title":"Annu Rev Pathol"},{"key":"556_CR23","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.metabol.2015.09.017","volume":"65","author":"A Lonardo","year":"2016","unstructured":"Lonardo A, Sookoian S, Pirola CJ, Targher G. Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism. 2016;65:1136\u201350.","journal-title":"Metabolism"},{"key":"556_CR24","doi-asserted-by":"publisher","unstructured":"Tang K, Zheng X, Lin J, Zheng M, Lin H, Li T, Wang L. Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by 18F-fluorodeoxyglucose positron emission tomography. J Nucl Cardiol. 2018. https:\/\/doi.org\/10.1007\/s12350-018-1446-x.","DOI":"10.1007\/s12350-018-1446-x"},{"key":"556_CR25","doi-asserted-by":"publisher","unstructured":"Clifford SM, Murphy DJ. Non-alcoholic fatty liver disease and coronary atherosclerosis-does myocardial glucose metabolism provide the missing link? J Nucl Cardiol. 2019. https:\/\/doi.org\/10.1007\/s12350-019-01783-z.","DOI":"10.1007\/s12350-019-01783-z"},{"key":"556_CR26","doi-asserted-by":"publisher","unstructured":"Tang K, Lin J, Ji X, Lin T, Sun D, Zheng X, Wang L. Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis. J Nucl Cardiol. 2019. https:\/\/doi.org\/10.1007\/s12350-019-01736-6.","DOI":"10.1007\/s12350-019-01736-6"},{"key":"556_CR27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.hfc.2012.06.005","volume":"8","author":"AR Aroor","year":"2012","unstructured":"Aroor AR, Mandavia CH, Sowers JR. Insulin resistance and heart failure: molecular mechanisms. Heart Fail Clin. 2012;8:609\u201317.","journal-title":"Heart Fail Clin"},{"key":"556_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/hep.21983","volume":"47","author":"G Perseghin","year":"2008","unstructured":"Perseghin G, Lattuada G, De Cobelli F, Esposito A, Belloni E, Ntali G, Ragogna F, Canu T, Scifo P, Del Maschio A, Luzi L. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology. 2008;47:51\u20138.","journal-title":"Hepatology"},{"key":"556_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jacc.2003.11.003","volume":"43","author":"H Taegtmeyer","year":"2004","unstructured":"Taegtmeyer H, Razeghi P. Heart disease in diabetes--resist the beginnings. J Am Coll Cardiol. 2004;43:315.","journal-title":"J Am Coll Cardiol"},{"key":"556_CR30","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3748\/wjg.v20.i7.1724","volume":"20","author":"S Ballestri","year":"2014","unstructured":"Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20:1724\u201345.","journal-title":"World J Gastroenterol"},{"key":"556_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4161\/21623945.2014.978662","volume":"4","author":"CL Gentile","year":"2015","unstructured":"Gentile CL, Weir TL, Cox-York KA, Wei Y, Wang D, Reese L, Moran G, Estrada A, Mulligan C, Pagliassotti MJ, Foster MT. The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD. Adipocyte. 2015;4:101\u201312.","journal-title":"Adipocyte"},{"key":"556_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00535-010-0340-3","volume":"46","author":"Y Eguchi","year":"2011","unstructured":"Eguchi Y, Mizuta T, Sumida Y, Ishibashi E, Kitajima Y, Isoda H, Horie H, Tashiro T, Iwamoto E, Takahashi H, Kuwashiro T, Soejima S, Kawaguchi Y, Oda Y, Emura S, Iwakiri R, Ozaki I, Eguchi T, Ono N, Anzai K, Fujimoto K, Koizumi S. The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease. J Gastroenterol. 2011;46:70\u20138.","journal-title":"J Gastroenterol"},{"key":"556_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1148\/radiol.10091790","volume":"256","author":"JR Van Werven","year":"2010","unstructured":"Van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, Ten Kate FJ, Van Gulik TM, Stoker J. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology. 2010;256:159\u201368.","journal-title":"Radiology"},{"key":"556_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-014-0162-3","volume":"14","author":"G Kim","year":"2015","unstructured":"Kim G, Jo K, Kim KJ, Lee YH, Han E, Yoon HJ, Wang HJ, Kang ES, Yun M. Visceral adiposity is associated with altered myocardial glucose uptake measured by (18) FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes. Cardiovasc Diabetol. 2015;14:1\u201310.","journal-title":"Cardiovasc Diabetol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-020-00556-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-020-00556-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-020-00556-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T23:19:06Z","timestamp":1622071146000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-020-00556-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1186\/s12902-020-00556-x","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"11 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of the Third Affiliated Hospital of Soochow University, and written informed consent was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}